BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37899285)

  • 1. Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.
    Yoon CY; Shin MC; Kim P; Shin YK; Kim WJ
    Korean J Ophthalmol; 2023 Dec; 37(6):477-484. PubMed ID: 37899285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
    Takayama K; Someya H; Yokoyama H; Takamura Y; Morioka M; Sameshima S; Ueda T; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
    Sci Rep; 2019 Oct; 9(1):14858. PubMed ID: 31619708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
    Nadal J; Carreras E; Canut MI
    Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Antoszyk AN; Glassman AR; Beaulieu WT; Jampol LM; Jhaveri CD; Punjabi OS; Salehi-Had H; Wells JA; Maguire MG; Stockdale CR; Martin DF; Sun JK;
    JAMA; 2020 Dec; 324(23):2383-2395. PubMed ID: 33320223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
    Abd Elhamid AH; Mohamed AAEA; Khattab AM
    BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
    BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
    Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
    Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.
    Kiuchi Y; Nakae K; Saito Y; Ito S; Ito N
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1627-32. PubMed ID: 16639623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
    Khuthaila MK; Hsu J; Chiang A; DeCroos FC; Milder EA; Setlur V; Garg SJ; Spirn MJ
    Am J Ophthalmol; 2013 Apr; 155(4):757-63, 763.e1-2. PubMed ID: 23317651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
    Nisic F; Gadzo AP; Fajkic A; Nisic A; Miokovic AP; Damjanovic G; Begic E; Beslic N; Lepara O
    Rom J Ophthalmol; 2023; 67(3):283-288. PubMed ID: 37876512
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
    Jiang T; Gu J; Zhang P; Chen W; Chang Q
    BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.
    Patel V; Rohowetz LJ; Pakravan P; Kalavar M; Yannuzzi NA; Sridhar J
    Clin Ophthalmol; 2023; 17():471-478. PubMed ID: 36755887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
    Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
    Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study.
    Yeh PT; Yang CM; Yang CH; Huang JS
    Ophthalmology; 2005 Dec; 112(12):2095-102. PubMed ID: 16225926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation.
    Park YJ; Ahn J; Kim TW; Park SJ; Joo K; Park KH; Shin JY
    Eye (Lond); 2021 Nov; 35(11):3056-3063. PubMed ID: 33420422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
    Ahn J; Woo SJ; Chung H; Park KH
    Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
    Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
    Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular Fibrin Glue to Lower the Risk of Postoperative Vitreous Hemorrhage After Diabetic Pars Plana Vitrectomy.
    Mansour HA; Mahmoudzadeh R; Hsu J
    Retina; 2023 Dec; 43(12):2148-2152. PubMed ID: 36731110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescein angiography of peripheral retina and pars plana during vitrectomy for proliferative diabetic retinopathy.
    Terasaki H; Miyake Y; Awaya S
    Am J Ophthalmol; 1997 Mar; 123(3):370-6. PubMed ID: 9063247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
    Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.